Viewing StudyNCT03626688



Ignite Creation Date: 2024-05-06 @ 11:54 AM
Last Modification Date: 2024-10-26 @ 12:51 PM
Study NCT ID: NCT03626688
Status: RECRUITING
Last Update Posted: 2024-04-18
First Post: 2018-07-27

Brief Title: A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
Sponsor:
Organization: United Therapeutics

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 1000
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: